Mexichem Acquires License for DuPont’s Medical Propellant
Mexichem announced that it acquired the distribution and sale license for HFC-227ea/P from Du Pont.
Mexichem announced on Dec. 31, 2014 that it acquired the distribution and sale license for pharmaceutical grade HFC-227ea/P, a medical propellant, from DuPont de Nemours and Company. The product, which is used to safely deliver drugs in aerosol form, will be added to Mexichem’s existing Zephex brand of medical propellants, which make up around 75% of the inhalers produced worldwide, according to the press release.
“Since 1995 Zephex products have filled around 3.5 billion inhalers, helping to improve the lives of over 100 million people every year. This acquisition highlights our continued commitment to leading the market and will allow us to further support a valuable part of our customer’s product portfolios,” said Simon Gardner, general manager of Mexichem Fluor Medical Products, in a press release.
Source: Mexichem
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
